4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-21-009920
Options or other derivatives
- COO & Chief Financial Officer acquired 40,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
LOWE CHRISTOPHER P. · COO & Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-09 | Grant or award : show line 1 in the form Employee Stock Option (right to buy) | +40,000 | 40,000 | D |
Loading xslF345X03/doc4.xml…